Innomed Ventures

Total investments

7

Average round size

14M

Portfolio companies

5

Lead investments

2

Follow on index

0.29

Exits

3

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalTherapeuticsBiopharma

Summary

The venture was found in Asia in Israel. The main department of described VC is located in the Jerusalem.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. When the investment is from Innomed Ventures the average startup value is 10-50 millions dollars. Speaking about the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. This Innomed Ventures works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2014. The high activity for fund was in 2004.

Among the various public portfolio startups of the fund, we may underline Notal Vision, Impliant, Glucon Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Biotechnology, Medical. The fund has specific favorite in a number of founders of portfolio startups.

The typical case for the fund is to invest in rounds with 4 participants. Despite the Innomed Ventures, startups are often financed by Psilos Group, Pelion Venture Partners, California Technology Ventures. The meaningful sponsors for the fund in investment in the same round are Psilos Group, Pelion Venture Partners, California Technology Ventures. In the next rounds fund is usually obtained by Telegraph Hill Partners, QuestMark Partners, Psilos Group.

Show more

Investments analytics

Analytics

Total investments
7
Lead investments
2
Exits
3
Follow on index
0.29
Investments by industry
  • Medical (5)
  • Biotechnology (5)
  • Health Care (5)
  • Medical Device (3)
  • Therapeutics (1)
  • Show 2 more
Investments by region
  • United States (6)
  • Israel (1)
Peak activity year
2004

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
19
Avg. valuation at time of investment
46M
Group Appearance index
0.86
Avg. company exit year
13
Avg. multiplicator
0.66

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
AngioScore 23 Aug 2004 Biotechnology, Health Care, Medical Early Stage Venture 15M United States, California, Fremont

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.